Principal Financial Group Inc. Takes Position in Strata Critical Medical $SRTA

Principal Financial Group Inc. purchased a new stake in shares of Strata Critical Medical (NASDAQ:SRTA) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 128,573 shares of the company’s stock, valued at approximately $537,000. Principal Financial Group Inc. owned approximately 0.15% of Strata Critical Medical as of its most recent SEC filing.

Separately, Seelaus Asset Management LLC raised its holdings in Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after purchasing an additional 6,000 shares in the last quarter. Institutional investors own 47.36% of the company’s stock.

Strata Critical Medical Trading Down 1.4%

Shares of SRTA opened at $5.02 on Friday. The stock has a market capitalization of $434.38 million, a PE ratio of -62.75 and a beta of 2.22. Strata Critical Medical has a fifty-two week low of $3.67 and a fifty-two week high of $6.50. The business has a 50-day simple moving average of $5.52.

Strata Critical Medical (NASDAQ:SRTA) last released its earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The firm had revenue of $67.38 million during the quarter. On average, sell-side analysts forecast that Strata Critical Medical will post -0.14 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings raised Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Strata Critical Medical currently has an average rating of “Moderate Buy” and an average price target of $8.00.

Insider Buying and Selling

In related news, CAO Amir Cohen sold 4,655 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $27,324.85. Following the completion of the transaction, the chief accounting officer owned 146,608 shares of the company’s stock, valued at $860,588.96. This trade represents a 3.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO William A. Heyburn sold 31,671 shares of Strata Critical Medical stock in a transaction on Monday, June 8th. The shares were sold at an average price of $5.87, for a total value of $185,908.77. Following the transaction, the chief executive officer owned 1,548,997 shares of the company’s stock, valued at $9,092,612.39. The trade was a 2.00% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 116,931 shares of company stock worth $687,184 in the last 90 days. Insiders own 15.50% of the company’s stock.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.